202 related articles for article (PubMed ID: 34745996)
1. Neoadjuvant Chemotherapy Followed by Radiofrequency Ablation Prolongs Survival for Ablatable Colorectal Liver Metastasis: A Propensity Score Matching Comparative Study.
Chen Y; Xu Y; Xu L; Han F; Huang Y; Jiang H; Wu J; Zhang Y
Front Oncol; 2021; 11():758552. PubMed ID: 34745996
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant Chemotherapy Followed by Radiofrequency Ablation May Be a New Treatment Modality for Colorectal Liver Metastasis: A Propensity Score Matching Comparative Study.
Chen Y; Huang Y; Xu L; Wu J; Han F; Jiang H; Zheng P; Xu D; Zhang Y
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358739
[TBL] [Abstract][Full Text] [Related]
3. Repeat Local Treatment of Recurrent Colorectal Liver Metastases, the Role of Neoadjuvant Chemotherapy: An Amsterdam Colorectal Liver Met Registry (AmCORE) Based Study.
Dijkstra M; Nieuwenhuizen S; Puijk RS; Timmer FEF; Geboers B; Schouten EAC; Opperman J; Scheffer HJ; de Vries JJJ; Versteeg KS; Lissenberg-Witte BI; Meijerink MR; van den Tol MP
Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638481
[TBL] [Abstract][Full Text] [Related]
4. Oncological outcomes and predictors of radiofrequency ablation of colorectal cancer liver metastases.
Wang CZ; Yan GX; Xin H; Liu ZY
World J Gastrointest Oncol; 2020 Sep; 12(9):1044-1055. PubMed ID: 33005297
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the therapeutic efficacy between systemic chemotherapy with and without radiofrequency ablation for colorectal cancer liver metastases: A propensity score matching study.
Hao W; Jun Z; Yan L; Zhong-Yi Z; Bin-Bin J; Gui-Ju L; Wei Y; Lin S; Kun Y
Br J Radiol; 2023 Aug; 96(1148):20221195. PubMed ID: 37191629
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy improves overall survival in resectable colorectal liver metastases patients with high clinical risk scores-- A retrospective, propensity score matching analysis.
Chen FL; Wang YY; Liu W; Xing BC
Front Oncol; 2022; 12():973418. PubMed ID: 36132151
[TBL] [Abstract][Full Text] [Related]
7. Primary Tumor Sidedness, RAS and BRAF Mutations and MSI Status as Prognostic Factors in Patients with Colorectal Liver Metastases Treated with Surgery and Thermal Ablation: Results from the Amsterdam Colorectal Liver Met Registry (AmCORE).
Dijkstra M; Nieuwenhuizen S; Puijk RS; Timmer FEF; Geboers B; Schouten EAC; Opperman J; Scheffer HJ; de Vries JJJ; Versteeg KS; Lissenberg-Witte BI; van den Tol MP; Meijerink MR
Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440165
[TBL] [Abstract][Full Text] [Related]
8. Thermal Ablation Compared to Partial Hepatectomy for Recurrent Colorectal Liver Metastases: An Amsterdam Colorectal Liver Met Registry (AmCORE) Based Study.
Dijkstra M; Nieuwenhuizen S; Puijk RS; Timmer FEF; Geboers B; Schouten EAC; Opperman J; Scheffer HJ; Vries JJJ; Swijnenburg RJ; Versteeg KS; Lissenberg-Witte BI; van den Tol MP; Meijerink MR
Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34199556
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous radiofrequency ablation of solitary hepatic metastases from colorectal cancer: risk factors of local tumor progression-free survival and overall survival.
Lee HJ; Lee MW; Ahn SH; Cha DI; Ko SE; Kang TW; Song KD; Rhim H
Ultrasonography; 2022 Oct; 41(4):728-739. PubMed ID: 35909318
[TBL] [Abstract][Full Text] [Related]
10. Nomogram including chemotherapy response for prediction of intrahepatic progression-free survival in patients with colorectal liver metastasis through chemotherapy followed by radiofrequency ablation.
Wu H; Liu GJ; Zhang ZY; Wu W; Meng YF; Wang S; Yang W; Yan K
Int J Hyperthermia; 2021; 38(1):633-639. PubMed ID: 33882789
[TBL] [Abstract][Full Text] [Related]
11. From the completion of neoadjuvant chemotherapy to surgery for colorectal cancer liver metastasis: What is the optimal timing?
Chen Q; Mao R; Zhao J; Bi X; Li Z; Huang Z; Zhang Y; Zhou J; Zhao H; Cai J
Cancer Med; 2020 Nov; 9(21):7849-7862. PubMed ID: 32886456
[TBL] [Abstract][Full Text] [Related]
12. Survival Evidence of Local Control for Colorectal Cancer Liver Metastases by Hepatectomy and/or Radiofrequency Ablation.
Canseco LM; Liu YW; Lu CC; Lee KC; Chen HH; Hu WH; Tsai KL; Yang YH; Wang CC; Hung CH
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760404
[TBL] [Abstract][Full Text] [Related]
13. Hepatectomy vs radiofrequency ablation for colorectal liver metastasis: a propensity score analysis.
Lee H; Heo JS; Cho YB; Yun SH; Kim HC; Lee WY; Choi SH; Choi DW
World J Gastroenterol; 2015 Mar; 21(11):3300-7. PubMed ID: 25805937
[TBL] [Abstract][Full Text] [Related]
14. Multielectrode Radiofrequency Ablation for Resectable Metachronous Liver Metastasis from Colorectal Cancer.
Cheng HY; Huang KW; Liang JT; Lin BR; Huang J; Hung JS; Chen CL
J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34442007
[TBL] [Abstract][Full Text] [Related]
15. Postoperative adjuvant chemotherapy is important for improving long-term survival in patients with colorectal cancer liver metastases undergoing simultaneous resection.
Zhong W; Xu B; Lu Y; Chang J; Xu L; Zhao H; Che X
J Gastroenterol Hepatol; 2024 May; 39(5):908-919. PubMed ID: 38323685
[TBL] [Abstract][Full Text] [Related]
16. The prognosis of radiofrequency ablation versus hepatic resection for patients with colorectal liver metastases: A systematic review and meta-analysis based on 22 studies.
Yang G; Wang G; Sun J; Xiong Y; Li W; Tang T; Li J
Int J Surg; 2021 Mar; 87():105896. PubMed ID: 33588125
[TBL] [Abstract][Full Text] [Related]
17. A Single-Center Retrospective Analysis of Periprocedural Variables Affecting Local Tumor Progression after Radiofrequency Ablation of Colorectal Cancer Liver Metastases.
Han K; Kim JH; Yang SG; Park SH; Choi HK; Chun SY; Kim PN; Park J; Lee M
Radiology; 2021 Jan; 298(1):212-218. PubMed ID: 33170105
[TBL] [Abstract][Full Text] [Related]
18. Improved Outcomes of Thermal Ablation for Colorectal Liver Metastases: A 10-Year Analysis from the Prospective Amsterdam CORE Registry (AmCORE).
Puijk RS; Dijkstra M; van den Bemd BAT; Ruarus AH; Nieuwenhuizen S; Geboers B; Timmer FEF; Schouten EAC; de Vries JJJ; van der Meijs BB; Nielsen K; Swijnenburg RJ; van den Tol MP; Versteeg KS; Lissenberg-Witte BI; Scheffer HJ; Meijerink MR
Cardiovasc Intervent Radiol; 2022 Aug; 45(8):1074-1089. PubMed ID: 35585138
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant Chemotherapy Versus Upfront Surgery for Resectable Liver Metastases from Colorectal Cancer: a Multicenter, Propensity Score-Matched Cohort Study.
Hirokawa F; Ueno M; Nakai T; Kaibori M; Nomi T; Iida H; Tanaka S; Komeda K; Hayami S; Kosaka H; Hokuto D; Kubo S; Uchiyama K
J Gastrointest Surg; 2022 Apr; 26(4):772-781. PubMed ID: 34664190
[TBL] [Abstract][Full Text] [Related]
20. [Comparative study on prognosis of neoadjuvant chemotherapy followed by hepatic surgery versus upfront surgery in patients with synchronous colorectal liver metastasis].
Wang LJ; Wang HW; Jin KM; Liu W; Bao Q; Wang K; Xing BC
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):248-255. PubMed ID: 34645169
[No Abstract] [Full Text] [Related]
[Next] [New Search]
